The Enterprise Value as of December 2025 (TTM) for aTyr Pharma, Inc. (ATYR) is 87.32M

According to aTyr Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 87.32M. This represents a change of -68.08% compared to the average of 273.54M of the last 4 quarters.

aTyr Pharma, Inc. (ATYR) Historical Enterprise Value (quarterly & annually)

How has ATYR Enterprise Value performed in the past?

The mean historical Enterprise Value of aTyr Pharma, Inc. over the last ten years is 37.53M. The current 87.32M Enterprise Value has changed 23.17% with respect to the historical average. Over the past ten years (40 quarters), ATYR's Enterprise Value was at its highest in in the June 2025 quarter at 452.37M. The Enterprise Value was at its lowest in in the March 2016 quarter at -46855849.96.

aTyr Pharma, Inc. (ATYR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of aTyr Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

aTyr Pharma, Inc. (ATYR) Average Enterprise Value

How has ATYR Enterprise Value performed in the past?

The current Enterprise Value of aTyr Pharma, Inc. (ATYR) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

aTyr Pharma, Inc. (ATYR) Enterprise Value vs. Peers

How is ATYR’s Enterprise Value compared to its peers?

aTyr Pharma, Inc.’s Enterprise Value is greater than ALX Oncology Holdings Inc. (71.16M), greater than CAMP4 Therapeutics Corporation (40.08M), less than Quince Therapeutics, Inc. (201.00M), greater than Metagenomi, Inc. Common Stock (83.35M), greater than Repare Therapeutics Inc. (23.36M), greater than Unicycive Therapeutics, Inc. (72.37M), less than Relmada Therapeutics, Inc. (291.98M), greater than Acrivon Therapeutics, Inc. Common Stock (43.63M), less than MindWalk Holdings Corp. (132.07M), greater than Precision BioSciences, Inc. (23.13M),

Build a custom stock screener for aTyr Pharma, Inc. (ATYR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like aTyr Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

aTyr Pharma, Inc. (ATYR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like aTyr Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.